Intellia Therapeutics, Inc. (NTLA) vs Pacific Biosciences of Californ (PACB)
Detailed comparison between Intellia Therapeutics, Inc., Pacific Biosciences of Californ.Total Return (%)
Intellia Therapeutics, Inc. (NTLA)Pacific Biosciences of Californ (PACB)
Which stock do you think will perform better?
Intellia Therapeutics, Inc.
NTLA
Pacific Biosciences of Californ
PACB
| Metric | Intellia Therapeutics, Inc. (NTLA) | Pacific Biosciences of Californ (PACB) |
|---|---|---|
| Current Price | $16.92 | $1.25 |
| Change | 0.61 (3.74%) | 0.04 (3.31%) |
| Market Cap | $1.82B | $0.38B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -3.07 | -1.84 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $21.47 | $2.72 |
| 52-Week Low | $5.90 | $0.85 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-4.87 | $-2.30 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NTLA | 48.42% | 63.95% | -11.88% | -15.78% | -23.44% | -23.44% |
| PACB | -2.34% | -18.83% | -22.84% | -88.10% | -77.06% | -65.85% |